Ultrasound Elasticity Imaging of Venous Thrombi
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to see if the investigators can use ultrasound imaging to determine the type of clots in patients to help better manage their care.
| Condition | Intervention | Phase |
|---|---|---|
|
Thrombosis |
Procedure: Ultrasound |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Aging Venous Thrombi With Ultrasound Elasticity Imaging |
- To determine if ultrasound imaging will aid in the diagnosis and classification of venous blood clots [ Designated as safety issue: No ]
- Follow-up with subjects who have been diagnosed with Acute DVT to see if they develop post-thrombotic syndrome (PTS) [ Time Frame: first year following diagnosis of acute DVT ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 86 |
| Study Start Date: | December 2002 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Ultrasound imaging of Acute DVT
|
Procedure: Ultrasound
Ultrasound imaging of Acute DVT
|
|
Experimental: 2
Ultrasound imaging of Chronic DVT
|
Procedure: Ultrasound
Ultrasound imaging of Chronic DVT
|
Detailed Description:
Deep vein thrombosis (DVT) is a blood clot and is a common illness that can result in pain and death if not recognized and treated well. Death can occur when the venous clots break off and form pulmonary emboli (PE), which can block the arteries of the lungs. DVT and PE most often complicate the course of sick patients but may also affect healthy persons. DVT can also be a chronic disease. In those instances in which DVT and PE develop, in addition to the death risk, hospitalization is drawn out and healthcare costs are increased. Therefore, the purpose of this study is to see if we can use ultrasound imaging to determine the type of clots in patients to help better manage their care.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Male or female subjects who have a diagnosis of chronic DVT that is at least 2 weeks old and are free from an acute DVT on top of your chronic DVT.
- Male and female patients who have been diagnosed with an acute blood clot by the Diagnostic Vascular Lab and w/symptoms occurring within the previous 2 weeks.
- Patients under the age of 18 who give assent (permission) and whose parents give consent.
- Adult patients who give consent.
Exclusion Criteria:
- None
Contacts and Locations| United States, Michigan | |
| University of Michigan Health System | |
| Ann Arbor, Michigan, United States, 48109 | |
| Principal Investigator: | Jonathan Rubin, M.D. | University of Michigan Health System |
More Information
No publications provided
| Responsible Party: | Jonathan Rubin, M.D., University of Michigan Health System |
| ClinicalTrials.gov Identifier: | NCT00726947 History of Changes |
| Other Study ID Numbers: | HUM 0040239, NIH ROI HL 78656-01A1 |
| Study First Received: | July 29, 2008 |
| Last Updated: | September 23, 2010 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Thrombosis Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 21, 2013